Balancing bias, reliability, noise properties and the need for parametric maps in quantitative ligand PET: [11C]diprenorphine test-retest data

NeuroImage

Volumn 38, Issue 1, 2007, Pages 82-94

  Hammers, Alexander ^a,b   Asselin, Marie Claude ^c,d   Turkheimer, Federico E ^a   Hinz, Rainer ^c,d   Osman, Safiye ^c   Hotton, Gary ^a   Brooks, David J ^a,c   Duncan, John S ^b   Koepp, Matthias J ^a,b  

^a MRC CLINICAL SCIENCES CENTRE   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c GE HEALTHCARE   (United Kingdom)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Diprenorphine; Opioid receptors; Positron emission tomography; Reproducibility; Spectral analysis

Indexed keywords

CARBON 11; DIPRENORPHINE; OPIATE RECEPTOR; RADIOLIGAND;

ADULT; ARTICLE; ARTIFACT REDUCTION; CEREBELLUM; CORRELATION COEFFICIENT; DEMOGRAPHY; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN EXPERIMENT; IMAGE PROCESSING; IMAGE QUALITY; MALE; NEUROIMAGING; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOCHEMISTRY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SIGNAL NOISE RATIO; STATISTICAL ANALYSIS; TEST RETEST RELIABILITY; THALAMUS;

ADULT; AGED; ALGORITHMS; ARTIFACTS; BRAIN; CARBON RADIOISOTOPES; DIPRENORPHINE; FEMALE; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RECEPTORS, OPIOID; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 34548841680     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2007.06.035     Document Type: Article

References (61)

1. Allen E.V. Throboangiitis obliterans: methods of diagnosis of chronic occlusive arterial lesions distal to the wrist with illustrative cases. Am. J. Med. Sci. 2 (1929) 1-8
2. Ashburner J., and Friston K.J. Voxel-based morphometry-The methods. NeuroImage 11 (2000) 805-821
3. Ashburner J., Andersson J.L., and Friston K.J. Image registration using a symmetric prior-in three dimensions. Hum. Brain Mapp. 9 (2000) 212-225
4. 11C]diprenorphine studies [abstract]. J. Cereb. Blood Flow Metab. 23 (2003) 679 (Suppl.)
5. Bailey D.L., Miller M.P., Spinks T.J., Bloomfield P.M., Livieratos L., Young H.E., and Jones T. Experience with fully 3D PET and implications for future high-resolution 3D tomographs. Phys. Med. Biol. 43 (1998) 777-786
6. Blomqvist G. On the construction of functional maps in positron emission tomography. J. Cereb. Blood Flow Metab. 4 (1984) 629-632
7. Bloomfield P.M., Spinks T.J., Reed J., Schnorr L., Westrip A.M., Livieratos L., Fulton R., and Jones T. The design and implementation of a motion correction scheme for neurological PET. Phys. Med. Biol. 48 (2003) 959-978
8. Costa C.D. Can ROI methodology/normalised tissue activities be used instead of absolute blood flow measurements in the brain?. For. Eur. J. Nucl. Med. 29 (2002) 948-953
9. Cunningham V.J., and Jones T. Spectral analysis of dynamic PET studies. J. Cereb. Blood Flow Metab. 13 (1993) 15-23
10. Cunningham V.J., Hume S.P., Price G.R., Ahier R.G., Cremer J.E., and Jones A.K. Compartmental analysis of diprenorphine binding to opiate receptors in the rat in vivo and its comparison with equilibrium data in vitro. J. Cereb. Blood Flow Metab. 11 (1991) 1-9
11. Cunningham V.J., Gunn R.N., and Matthews J.C. Quantification in positron emission tomography for research in pharmacology and drug development. Nucl. Med. Commun. 25 (2004) 643-646
12. Dupont W.D., and Plummer W.D. Power and sample size calculations: a review and computer program. Control. Clin. Trials 11 (1990) 116-128
13. 11C-DASB in healthy humans: reproducibility and comparison of methods. J. Nucl. Med. 47 (2006) 815-826
14. 11C]WAY-100635 for PET. NeuroImage 8 (1998) 426-440
15. 11C]WAY-100635 PET studies. Nucl. Med. Biol. 27 (2000) 477-482
16. Gunn R.N., Gunn S.R., Turkheimer F.E., Aston J.A., and Cunningham V.J. Positron emission tomography compartmental models: a basis pursuit strategy for kinetic modeling. J. Cereb. Blood Flow Metab. 22 (2002) 1425-1439
17. Hallett W.A. Quantification in clinical fluorodeoxyglucose positron emission tomography. Nucl. Med. Commun. 25 (2004) 647-650
18. Hammers A., and Lingford-Hughes A. Opioid imaging. Neuroimaging Clin. N. Am. 16 (2006) 529-552
19. Hammers A., Allom R., Koepp M.J., Free S.L., Myers R., Lemieux L., Mitchell T.N., Brooks D.J., and Duncan J.S. Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe. Hum. Brain Mapp. 19 (2003) 224-247
20. Herzog H., Tellmann L., Fulton R., Stangier I., Kops E.R., Bente K., Boy C., Hurlemann R., and Pietrzyk U. Motion artifact reduction on parametric PET images of neuroreceptor binding. J. Nucl. Med. 46 (2005) 1059-1065
21. Hinz R., and Turkheimer F.E. Determination of tracer arrival delay with spectral analysis. IEEE Trans. Nucl. Sci. 53 (2006) 212-219
22. 11C]SCH23390: a test-Retest analysis. J. Cereb. Blood Flow Metab. 21 (2001) 1133-1145
23. 11C-raclopride. Nucl. Med. Commun. 24 (2003) 1207-1214
24. 11C]flumazenil. J. Cereb. Blood Flow Metab. 11 (1991) 745-752
25. Hume S.P., Gunn R.N., and Jones T. Pharmacological constraints associated with positron emission tomographic scanning of small laboratory animals. Eur. J. Nucl. Med. 25 (1998) 173-176
26. Itzhak Y., Bonnet K.A., Groth J., Hiller J.M., and Simon E.J. Multiple opiate binding sites in human brain regions: evidence for kappa and sigma sites. Life Sci. 31 (1982) 1363-1366
27. 11C]diprenorphine cerebral kinetics in man acquired by PET using presaturation, pulse-chase and tracer-only protocols. J. Neurosci. Methods 51 (1994) 123-134
28. Kinahan P.E., and Rogers J.G. Analytic 3D image reconstruction using all detected events. IEEE Trans. Nucl. Sci. 36 (1989) 964-968
29. Koepp M.J., Richardson M.P., Brooks D.J., Poline J.B., Van Paesschen W., Friston K.J., and Duncan J.S. Cerebral benzodiazepine receptors in hippocampal sclerosis. An objective in vivo analysis. Brain 119 (1996) 1677-1687
30. Koepp M.J., Gunn R.N., Lawrence A.D., Cunningham V.J., Dagher A., Jones T., Brooks D.J., Bench C.J., and Grasby P.M. Evidence for striatal dopamine release during a video game. Nature 393 (1998) 266-268
31. Koepp M.J., Richardson M.P., Brooks D.J., and Duncan J.S. Focal cortical release of endogenous opioids during reading-induced seizures. Lancet 352 (1998) 952-955
32. 11C](R)-PK11195 studies. J. Cereb. Blood Flow Metab. 26 (2006) 1431-1441
33. Lammertsma A.A., and Hume S.P. Simplified reference tissue model for PET receptor studies. NeuroImage 4 (1996) 153-158
34. Laruelle M. Modelling: when and why?. Eur. J. Nucl. Med. 26 (1999) 571-572
35. 11C-methyl]-(-)-cocaine PET studies in human subjects. J. Cereb. Blood Flow Metab. 10 (1990) 740-747
36. 11C-buprenorphine. J. Label. Compd. Radiopharm. 30 (1991) 258
37. 11C]Schering 23390. J. Label. Compd. Radiopharm. 32 (1993) 518-520
38. Maes F., Collignon A., Vandermeulen D., Marchal G., and Suetens P. Multimodality image registration by maximization of mutual information. IEEE Trans. Med. Imag. 16 (1997) 187-198
39. 2 receptor parameter measurements in ventral striatum. J. Cereb. Blood Flow Metab. 21 (2001) 1034-1057
40. Mintun M.A., Raichle M.E., Kilbourn M.R., Wooten G.F., and Welch M.J. A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography. Ann. Neurol. 15 (1984) 217-227
41. Montgomery A.J., Thielemans K., Mehta M.A., Turkheimer F., Mustafovic S., and Grasby P.M. Correction of head movement on PET studies: comparison of methods. J. Nucl. Med. 47 (2006) 1936-1944
42. 11C]DASB and positron emission tomography in humans: modeling considerations. J. Cereb. Blood Flow Metab. (2006)
43. Pan X.B., Wright T.G., Leong F.J., McLaughlin R.A., Declerck J.M., and Silverman D.H. Improving influx constant and ratio estimation in FDOPA brain PET analysis for Parkinson's disease. J. Nucl. Med. 46 (2005) 1737-1744
44. 11C]WAY-100635 in humans: comparison of arterial and reference tisssue input functions. J. Cereb. Blood Flow Metab. 20 (2000) 1111-1133
45. Ranicar A.S., Williams C.W., Schnorr L., Clark J.C., Rhodes C.G., Bloomfield P.M., and Jones T. The on-line monitoring of continuously withdrawn arterial blood during PET studies using a single BGO/photomultiplier assembly and non-stick tubing. Med. Prog. Technol. 17 (1991) 259-264
46. 11C]methyl-l-tryptophan brain trapping in healthy male volunteers. Eur. J. Nucl. Med. Mol. Imaging 32 (2005) 1199-1204
47. Rudolf J., Sobesky J., Grond M., and Heiss W.D. Identification by positron emission tomography of neuronal loss in acute vegetative state. Lancet 355 (2000) 115-116
48. Schmidt K. Can ROI methodology/normalised tissue activities be used instead of absolute blood flow measurements in the brain? Against. Eur. J. Nucl. Med. 29 (2002) 953-956
49. Slifstein M., and Laruelle M. Models and methods for derivation of in vivo neuroreceptor parameters with PET and SPECT reversible radiotracers. Nucl. Med. Biol. 28 (2001) 595-608
50. 18F]diprenorphine kinetics in the human brain with compartmental and non-compartmental modeling approaches. NeuroImage 22 (2004) 1523-1533
51. Spinks T.J., Jones T., Bloomfield P.M., Bailey D.L., Miller M., Hogg D., Jones W.F., Vaigneur K., Reed J., Young J., Newport D., Moyers C., Casey M.E., and Nutt R. Physical characteristics of the ECAT EXACT3D positron tomograph. Phys. Med. Biol. 45 (2000) 2601-2618
52. Studholme C., Hill D.L.G., and Hawkes D.J. Automated three-dimensional registration of magnetic resonance and positron emission tomography brain images by multiresolution optimization of voxel similarity measures. Med. Phys. 24 (1997) 25-35
53. 11C]FLB 457 binding in extrastriatal regions. Nucl. Med. Commun. 22 (2001) 1215-1221
54. 11C-diprenorphine binding using spectral analysis of dynamic PET images acquired in 3D. In: Uemura K., Jones T., Lassen N.A., and Kanno I. (Eds). Quantification of Brain Function: Tracer Kinetics and Image Analysis in Brain PET (1993), Excerpta Medica, Amsterdam 289-294
55. Turkheimer F.E., Brett M., Visvikis D., and Cunningham V.J. Multiresolution analysis of emission tomography images in the wavelet domain. J. Cereb. Blood Flow Metab. 19 (1999) 1189-1208
56. Turkheimer F.E., Hinz R., Gunn R.N., Aston J.A., Gunn S.R., and Cunningham V.J. Rank-shaping regularization of exponential spectral analysis for application to functional parametric mapping. Phys. Med. Biol. 48 (2003) 3819-3841
57. 11C]diprenorphine PET study. Brain 128 (2005) 906-917
58. Watson C.C., Newport D., and Casey M.E. A single-scatter simulation technique for scatter correction in 3D PET fully three-dimensional images. In: Grangeat P., and Amans J.L. (Eds). Three-Dimensional Image Reconstruction in Radiology and Nuclear Medicine (1996), Kluwer Academic Publishers, Dordrecht, Boston 255-268
59. 11C-Diprenorphine binding in Huntington's disease: a comparison of region of interest analysis with statistical parametric mapping. J. Cereb. Blood Flow Metab. 17 (1997) 943-949
60. 11C-diprenorphine PET study. Mov. Disord. 19 (2004) 1498-1503
61. Zubieta J.K., Smith Y.R., Bueller J.A., Xu Y., Kilbourn M.R., Jewett D.M., Meyer C.R., Koeppe R.A., and Stohler C.S. Regional mu opioid receptor regulation of sensory and affective dimensions of pain. Science 293 (2001) 311-315